Operator

Ladies and gentlemen, greetings, and welcome to the Longeveron 2026 First Quarter Financial Results and Business Update Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Derek Cole from Investor Relations Advisory Solutions. Please go ahead.

Derek Cole
Investor Relations Advisory Solutions

Thank you, operator. Good afternoon, everyone, and thank you for joining us today to review Longeveron's 2026 First Quarter Financial Results and Business update. After the U.S. markets today, we issued a press release with financial results for the first quarter, which can be found under the Investors section of the Longeveron website. On the call today are Stephen Willard, Chief Executive Officer; Joshua Hare, Co-Founder, Chief Science Officer and Executive Chairman of the Board; Nataliya Agafonova, Chief Medical Officer; and Lisa Locklear, Chief Financial Officer.

As a reminder, during this call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from these statements. Any such statements should be considered in conjunction with cautionary statements in our press releases and risk factors discussed in the company's filings with the Securities and Exchange Commission, which we encourage you to review. Following the company's prepared remarks, we will open the call to questions from covering research analysts.

With that, let me hand over